Combined immune deficiency, autoantibody formation, and mucocutaneous candidiasis.
D000666:Amphotericin B / Q000627:therapeutic use; D000917:Antibody Formation; D000946:Antigens, Fungal; D001327:Autoimmune Diseases; D002179:Candidiasis, Cutaneous / Q000150:complications* / Q000188:drug therapy; D002648:Child; D004168:Diphtheria Toxoid; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007070:Immunoglobulin A / Q000032:analysis; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D008213:Lymphocyte Activation; D008231:Lymphopenia / Q000209:etiology; D008263:Macrophage Migration-Inhibitory Factors / Q000172:deficiency; D009130:Muscle, Smooth; D009578:Nitrobenzenes / Q000276:immunology; D010567:Pertussis Vaccine; D012882:Skin Tests; D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid; D013936:Thymidine / Q000378:metabolism; D014436:Typhoid-Paratyphoid Vaccines
D000946:Antigens, Fungal; D004168:Diphtheria Toxoid; D007070:Immunoglobulin A; D008263:Macrophage Migration-Inhibitory Factors; D009578:Nitrobenzenes; D010567:Pertussis Vaccine; D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid; D014436:Typhoid-Paratyphoid Vaccines; D000666:Amphotericin B; D013936:Thymidine